摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 3β-hydroxy-5β-cholane-12-one-24-oate acetate | 122441-64-9

中文名称
——
中文别名
——
英文名称
methyl 3β-hydroxy-5β-cholane-12-one-24-oate acetate
英文别名
methyl 3β-hydroxy-5β-cholan-12-on-24-oate acetate;3β-acetoxy-12-oxo-5β-cholanoic acid-(24)-methyl ester;3β-Acetoxy-12-oxo-5β-cholansaeure-(24)-methylester;methyl (4R)-4-[(3S,5R,8R,9S,10S,13R,14S,17R)-3-acetyloxy-10,13-dimethyl-12-oxo-1,2,3,4,5,6,7,8,9,11,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pentanoate
methyl 3β-hydroxy-5β-cholane-12-one-24-oate acetate化学式
CAS
122441-64-9
化学式
C27H42O5
mdl
——
分子量
446.627
InChiKey
XHQVLSIVZIPGLE-OESDZRLSSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    516.8±35.0 °C(Predicted)
  • 密度:
    1.10±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    5.5
  • 重原子数:
    32
  • 可旋转键数:
    7
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.89
  • 拓扑面积:
    69.7
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    methyl 3β-hydroxy-5β-cholane-12-one-24-oate acetate甲醇 、 sodium hydroxide 、 lithium hydroxide 作用下, 以 四氢呋喃 为溶剂, 反应 10.5h, 生成 去氧胆酸
    参考文献:
    名称:
    SYNTHETIC BILE ACID COMPOSITIONS AND METHODS
    摘要:
    胆汁酸及相关组合物的合成和使用方法。更具体地说,脱氧胆酸及相关组合物,所述组合物不含任何动物来源的成分和不含热原性成分。
    公开号:
    US20130252931A1
  • 作为产物:
    参考文献:
    名称:
    Lidocaine added to a tracheostomy tube cuff reduces tube discomfort
    摘要:
    Purpose: To examine whether lidocaine diffusion across an endotracheal tube cuff affects tracheostomy tube discomfort.Methods: Two tracheostomy tube cuffs were inflated with 5 mi lidocaine 4% solution and air at 20 cmH(2)O, and then placed in 20 mi distilled water at 37 degrees C. After vigorous stirring, 100 mu l of this water was then sampled immediately then 1, 2, 4, 8, 24 hr later to measure lidocaine concentration by high-performance liquid chromatography. Sixteen patients undergoing tracheostomy following oral cancer resection were randomly assigned to two groups: lidocaine (n=8) and placebo (n=8), A tracheostomy tube cuff was inflated with 5 mi lidocaine 4% or saline 0.9% and air to a cuff pressure of 20 cmH(2)O, in the lidocaine and placebo groups respectively, Tube discomfort was evaluated using a visual analogue scale at 0, 0.5, 1, 2 and 4 hr after lidocaine or saline administration, Neither analgesics nor sedatives was given during the evaluation period.Results: Lidocaine lime-dependently diffused across the tracheostomy tube cuff. Thirty and 60 min after cuff inflation lidocaine concentrations in the water bath reached approximately 8 and 17 mu g.ml(-1) representing 160 and 340 mu g in 20 ml of water, respectively. The VAS decreased from 53.5 +/- 10.6 to 25.1 +/- 9.8 mm (P < 0.01) 0.5 hr following lidocaine administration which continued until the end of evaluation period, in the placebo group, VAS did not change.Conclusion: Lidocaine diffusion across the tracheostomy tube cuff reduces tube discomfort.
    DOI:
    10.1007/bf03018969
点击查看最新优质反应信息

文献信息

  • Synthetic bile acid compositions and methods
    申请人:Kythera Biopharmaceuticals, Inc.
    公开号:US08242294B2
    公开(公告)日:2012-08-14
    Bile acids and related compositions and methods of synthesis and use. More specifically, deoxycholic acid and related compositions, said compositions being free of all moieties of animal origin and free of pyrogenic moieties.
    胆酸及相关组成物的合成和使用方法。更具体地说,去氧胆酸和相关组成物,该组成物不含任何动物来源的成分和无热原成分。
  • Synthetic Bile Acid Composition, Method, and Preparation
    申请人:Kythera Biopharmaceuticals, Inc.
    公开号:EP2407475A2
    公开(公告)日:2012-01-18
    Bile acids and related compositions and methods of synthesis and use. More specifically, deoxycholic acid and related compositions, said compositions being free of all moieties of animal origin and free of pyrogenic moieties.
    胆汁酸和相关成分以及合成和使用方法。更具体地说,脱氧胆酸及相关组合物,所述组合物不含任何动物源性分子,也不含热源性分子。
  • [EN] SYNTHETIC BILE ACID COMPOSITIONS AND METHODS<br/>[FR] COMPOSITIONS D'ACIDES BILIAIRES SYNTHÉTIQUES ET PROCÉDÉS
    申请人:KYTHERA BIOPHARMACEUTICALS INC
    公开号:WO2012021133A9
    公开(公告)日:2012-06-07
  • synthetic bile acid preparation
    申请人:Kythera Biopharmaceuticals, Inc.
    公开号:EP2407475B1
    公开(公告)日:2015-08-12
  • WO2008157635A2
    申请人:——
    公开号:——
    公开(公告)日:——
查看更多

同类化合物

(5β)-17,20:20,21-双[亚甲基双(氧基)]孕烷-3-酮 (5α)-2′H-雄甾-2-烯并[3,2-c]吡唑-17-酮 (3β,20S)-4,4,20-三甲基-21-[[[三(异丙基)甲硅烷基]氧基]-孕烷-5-烯-3-醇-d6 (25S)-δ7-大发酸 (20R)-孕烯-4-烯-3,17,20-三醇 (11β,17β)-11-[4-({5-[(4,4,5,5,5-五氟戊基)磺酰基]戊基}氧基)苯基]雌二醇-1,3,5(10)-三烯-3,17-二醇 齐墩果酸衍生物1 黄麻属甙 黄芪皂苷III 黄芪皂苷 II 黄芪甲苷 IV 黄芪甲苷 黄肉楠碱 黄果茄甾醇 黄杨醇碱E 黄姜A 黄夹苷B 黄夹苷 黄夹次甙乙 黄夹次甙乙 黄夹次甙丙 黄体酮环20-(乙烯缩醛) 黄体酮杂质EPL 黄体酮杂质1 黄体酮杂质 黄体酮杂质 黄体酮EP杂质M 黄体酮EP杂质G(RRT≈2.53) 黄体酮EP杂质F 黄体酮6-半琥珀酸酯 黄体酮 17alpha-氢过氧化物 黄体酮 11-半琥珀酸酯 黄体酮 麦角甾醇葡萄糖苷 麦角甾醇氢琥珀酸盐 麦角甾烷-6-酮,2,3-环氧-22,23-二羟基-,(2b,3b,5a,22R,23R,24S)-(9CI) 麦角甾烷-3,6,8,15,16-五唑,28-[[2-O-(2,4-二-O-甲基-b-D-吡喃木糖基)-a-L-呋喃阿拉伯糖基]氧代]-,(3b,5a,6a,15b,16b,24x)-(9CI) 麦角甾烷-26-酸,5,6:24,25-二环氧-14,17,22-三羟基-1-羰基-,d-内酯,(5b,6b,14b,17a,22R,24S,25S)-(9CI) 麦角甾-8-烯-3-醇 麦角甾-8,24(28)-二烯-26-酸,7-羟基-4-甲基-3,11-二羰基-,(4a,5a,7b,25S)- 麦角甾-7,22-二烯-3-酮 麦角甾-7,22-二烯-17-醇-3-酮 麦角甾-5,24-二烯-26-酸,3-(b-D-吡喃葡萄糖氧基)-1,22,27-三羟基-,d-内酯,(1a,3b,22R)- 麦角甾-5,22,25-三烯-3-醇 麦角甾-4,6,8(14),22-四烯-3-酮 麦角甾-1,4-二烯-3-酮,7,24-二(乙酰氧基)-17,22-环氧-16,25-二羟基-,(7a,16b,22R)-(9CI) 麦角固醇 麦冬皂苷D 麦冬皂苷D 麦冬皂苷 B